EchoNous, the parent company of handheld ultrasound provider Signostics, has received another $35 million from investment firm KKR.
The new investment will be used to fund sales of the company's Uscan ultrasound visualization device for bladder and kidney care, as well as to pursue a vein-finding technique for nursing applications, according to the vendor. The company said it will also use the financing to bring an artificial intelligence-driven ultrasound project to market.
KKR initially invested $35 million in Signostics in 2015.
